Articles published by NICOX

Nicox: 2024 Ordinary and Extraordinary Shareholder Meeting
April 09, 2024
From NICOX
Via GlobeNewswire




Nicox Appoints Experienced Biotech Executive Gavin Spencer as CEO
February 28, 2024
From NICOX
Via GlobeNewswire


Nicox and Kowa Enter into Agreement for NCX 470 Development and Commercialization in Japan
February 08, 2024
From NICOX
Via GlobeNewswire



Nicox Provides Fourth Quarter 2023 Financial and Business Highlights
January 25, 2024
From NICOX
Via GlobeNewswire

Nicox Announces First Patient Screened in the Whistler Phase 3b Trial of NCX 470 in Glaucoma
December 18, 2023
From NICOX
Via GlobeNewswire



From NICOX
Via GlobeNewswire

From NICOX
Via GlobeNewswire



From NICOX
Via GlobeNewswire

From NICOX
Via GlobeNewswire

From NICOX
Via GlobeNewswire



From NICOX
Via GlobeNewswire


Nicox to Participate in Financial, Pharmaceutical Industry and Scientific Events in H1 2023
January 24, 2023
From NICOX
Via GlobeNewswire

Nicox Provides Fourth Quarter 2022 Financial Highlights
January 18, 2023
From NICOX
Via GlobeNewswire

Nicox Announces Proposed Move to Euronext Growth Paris
January 09, 2023
From NICOX
Via GlobeNewswire

From NICOX
Via GlobeNewswire


Nicox Provides Third Quarter 2022 Financial and Business Highlights
October 19, 2022
From NICOX
Via GlobeNewswire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.